SCHEMBL3701501

SCHEMBL3701501

C=CC[CH]c1ccc(C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.50
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 1/20 0.42
TDP1 Q9NUW8 2/20 0.40
ACHE P22303 1/20 0.40
NFE2L2 Q16236 2/20 0.39
KDM4E B2RXH2 2/20 0.37
RELA Q04206 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
RECQL P46063 1/20 0.37
MDM2 Q00987 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CA1 P00915 1/20 0.37
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7795364 0.77 CYP2A6 (0.52) CYP2A6RAB9ASMN1; SMN2NPC1TDP1
SCHEMBL310519 0.76 CYP2A6 (0.57) CYP2A6RAB9ASMN1; SMN2NPC1TDP1
SCHEMBL363138 0.75 ALDH5A1 (0.50) RAB9ASMN1; SMN2NPC1TDP1NFE2L2
SCHEMBL7428108 0.75 NFE2L2 (0.41) SMN1; SMN2NFE2L2MAPTL3MBTL1ALDH1A1
SCHEMBL7315800 0.75 ALDH1A1 (0.56) KDM4EALDH1A1FBP1
SCHEMBL4532036 0.75 ALDH1A1 (0.56) CYP2A6RAB9ASMN1; SMN2NPC1NFE2L2
SCHEMBL87669 0.74 ALDH1A1 (0.52) CYP2A6SMN1; SMN2NFE2L2L3MBTL1CYP2C19
SCHEMBL5469370 0.73 CYP2A6 (0.48) CYP2A6RAB9ASMN1; SMN2NPC1TDP1
SCHEMBL14911 0.73
SCHEMBL679555 0.73 ALDH1A1 (0.69) CYP2A6RAB9ASMN1; SMN2NPC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2207416-A1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM World Minerals, Inc. (US) 2010-07-21 EP disclosed
WO-2009045941-A1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM WORLD MINERALS, INC. (US) 2009-04-09 WO disclosed
EP-0666846-A4 1995-09-20 EP disclosed
EP-0666846-A1 NEW SUBSTITUTED AZETIDINONES AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS MERCK & CO. INC. (US) 1995-08-16 EP disclosed
WO-1994013636-A1 NEW SUBSTITUTED AZETIDINONES AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS MERCK & CO., INC. (US) 1994-06-23 WO disclosed
WO-1994010143-A1 NEW SUBSTITUTED AZETIDINONES AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS MERCK & CO., INC. (US) 1994-05-11 WO disclosed
US-5274080-A Binds to a urea-containing hapten MERCK & CO., INC. (US) 1993-12-28 US disclosed
US-5190929-A Cyclophosphamide derivatives RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-03-02 US disclosed
WO-1993000332-A1 SUBSTITUTED AZETIDINONES AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS MERCK & CO., INC. (US) 1993-01-07 WO disclosed
WO-1989011278-A1 CYCLOPHOSPHAMIDE ANALOGS USEFUL AS ANTI-TUMOR AGENTS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1989-11-30 WO disclosed